Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 7/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.36 |
| ▸ | CPB1 | P15086 | 1/20 | 0.36 |
| ▸ | CTSC | P53634 | 2/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.34 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1666820 | 1.00 | SLC15A2 (0.42) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL4588249 | 0.99 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL2811067 | 0.99 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| Hydrochloric Acid SCHEMBL2199717 | 0.99 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| Hydrochloric Acid SCHEMBL1436163 | 0.99 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL30954680 | 0.99 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL29590566 | 0.95 | SLC15A2 (0.49) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL20783813 | 0.95 | SLC15A2 (0.49) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL31453803 | 0.95 | SLC15A2 (0.49) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL29888249 | 0.91 | SLC15A2 (0.44) | SLC15A2ITGB3ITGA2BCPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119193245-B | Post-CMP cleaning solution for semiconductor cobalt process, preparation method and application thereof | 大连奥首科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119661691-A | N-terminal modified cosmetic polypeptide composition and synthesis method thereof | 湖南益安生物科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119060121-B | Synthesis method of oligopeptide-1 | 山东美欣生物科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119235684-A | Dermatological anti-wrinkle composition, preparation method and application thereof | 优然创新(北京)技术研发中心有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-119219728-A | Glycyl-L-histidine crystal form compound and preparation method thereof | 珠海瑞德林生物有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119193245-A | Post-CMP cleaning solution for semiconductor cobalt process, preparation method and application thereof | 大连奥首科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119060121-A | Synthesis process of oligopeptide-1 | 山东美欣生物科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-114671912-B | Method for homogeneously synthesizing blue copper tripeptide with assistance of light shearing carrier | 西北工业大学 | 2024-05-14 | — | — | CN | claimed |
| CN-113461774-B | Preparation method of palmitoyl tripeptide-1 | 深圳瑞德林生物技术有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-114671912-A | Method for homogeneous synthesis of blue copper tripeptide with assistance of photo-shearing carrier | 西北工业大学 | 2022-06-28 | — | — | CN | claimed |
| WO-1995005852-A1 | AGENT AGAINST SENSITIVE, HYPERREACTIVE AND HYPOACTIVE STATES OF THE SKIN, FORMS OF ACNE, ATOPIC DERMATITIDES, PSORIASIS, PRURIGO, PHOTODERMATOSES, ICHTHYOSIS AND VIRAL INFECTIONS | BEIERSDORF AG (DE) | 1995-03-02 | — | — | WO | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| EP-0291626-A2 | Process for the preparation of optically-active cyanomethyl esters | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-11-23 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| US-4570017-A | Preparation of optically-active (mixed) anhydrides and acids | SHELL OIL COMPANY (US) | 1986-02-11 | — | — | US | claimed |
| US-4560515-A | NON-SYMMETRICAL KETENE REACTED WITH A-HYDROXYNITRILE; TERTUARY AMINE CATALYST | SHELL OIL COMPANY (US) | 1985-12-24 | — | — | US | claimed |
| US-4529810-A | Preparation of optically-active alpha-substituted carboxylic esters and acids | SHELL OIL COMPANY (US) | 1985-07-16 | — | — | US | claimed |
| EP-0116914-A1 | Preparation of optically-active alpha-substituted carboxylic esters and acids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-08-29 | — | — | EP | claimed |
| EP-0109681-A2 | process for the preparation of optically-active cyanomethyl esters | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-05-30 | — | — | EP | claimed |